publication date: Dec. 8, 2017

In Brief William Oh named deputy director of Tisch Cancer Institute

William Oh was named deputy director of The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai.

Oh will oversee the clinical and translational research activities of TCI’s multi-disciplinary faculty with a goal of securing designation of TCI as an NCI Comprehensive Cancer Center.

The institution has the NCI Cancer Center designation, which was obtained in 2015.

A professor of medicine and urology and the Ezra M. Greenspan Professor in Clinical Cancer Therapeutics, Oh has served as chief of hematology and medical oncology for the Mount Sinai Health System and associate director for clinical and translational research for TCI since joining ISMMS in 2009. He will continue in these roles.

Prior to joining the School, Oh worked with the Dana-Farber Cancer Institute and Harvard Medical School for 14 years. He served as clinical director of the Lank Center for Genitourinary Oncology at the Dana-Farber Cancer Institute and was founding chair of the data safety monitoring committee at the Dana-Farber/Harvard Cancer Center.

Oh’s research is focused on the development of novel approaches to treating advanced prostate cancer, including therapies targeting cancer metabolism and DNA repair. Oh has helped in creating specimen and research databases that have led to novel biomarkers that predict … Continue reading William Oh named deputy director of Tisch Cancer Institute

To access this members-only content, please log in.
If you're not a subscriber why not join today?
If you believe you should be able to view this area but cannot log in, then please contact us and we will try to rectify this issue as soon as possible.
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2018 The Cancer Letter Inc.